Drospirenone / Ethinyl Estradiol
Drospirenone / ethinyl estradiol is a combination hormone pill used for birth control, moderate acne, and — in several brands — symptoms of premenstrual dysphoric disorder (PMDD).
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 31 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Women over 35 who smoke should not use this medication. Smoking while taking combination birth control pills — especially after age 35 — greatly increases the risk of serious and potentially fatal cardiovascular events, including heart attack, stroke, and blood clots. The more you smoke and the older you are, the higher the risk. If you are over 35 and smoke, talk to your doctor about a different method of contraception.
📖 Drospirenone / Ethinyl Estradiol: Patient Information Guide
A plain-language walkthrough of Drospirenone / Ethinyl Estradiol — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Drospirenone / ethinyl estradiol is a combination hormonal contraceptive used for several purposes, depending on the specific product:
- Preventing pregnancy — all products, including Yaz, Yasmin, Nikki, Ocella, Syeda, Loryna, Vestura, Jasmiel, Zumandimine, Lo-Zumandimine, and generics
- Treating moderate acne — approved for women at least 14 years old who also want to use an oral contraceptive for birth control; supported by Yaz, Nikki, Loryna, Vestura, Jasmiel, Lo-Zumandimine, and drospirenone / ethinyl estradiol generics
- Treating symptoms of PMDD (premenstrual dysphoric disorder) — only for those choosing oral contraception; supported by Yaz, Nikki, Loryna, Vestura, Jasmiel, Lo-Zumandimine, and drospirenone / ethinyl estradiol generics; effectiveness beyond three menstrual cycles has not been evaluated for this use
⚙️How it works▾
This pill combines two synthetic hormones: drospirenone, a progestin, and ethinyl estradiol, an estrogen. They work primarily by suppressing ovulation — preventing the ovaries from releasing an egg. They may also thicken cervical mucus so sperm cannot pass through as easily, and alter the uterine lining. Drospirenone is unique among progestins in that it has anti-androgenic (blocks male hormone) and anti-mineralocorticoid (mild potassium-retaining, like spironolactone) properties. The anti-androgenic activity may play a role in the improvement of acne, though the exact mechanism for the acne benefit has not been fully established.
💊How it's taken▾
Take one tablet by mouth at the same time every day, in the order shown on the blister pack — do not skip or rearrange tablets. You can start either on Day 1 of your menstrual period or on the first Sunday after your period begins, as directed by your prescriber. Missing pills or taking them out of order raises the chance of pregnancy.
- If you miss a single pill, take it as soon as you remember and continue the pack as normal
- Taking the pill with a high-fat meal may slow absorption slightly; always follow any food instructions on your specific product's label
- Follow your prescriber's and pharmacist's instructions for your specific brand, as pack lengths and pill colors vary by product
🤒Side effects — in detail▾
The most commonly reported side effects include:
- Headache or migraine
- Nausea or vomiting
- Breast pain or tenderness
- Irregular bleeding or spotting, especially in the first few months
- Mood changes, including depressed mood or mood swings
- Fatigue
- Decreased sex drive
- Weight gain
Serious reactions — including blood clots, stroke, liver problems, and severe high blood pressure — are less common but require immediate medical attention. Stop the pill and call your doctor or 911 if you experience sudden chest pain, severe headache, vision changes, or leg pain and swelling.
⚠️Warnings & precautions▾
- Blood clots (venous thromboembolism): This is the most serious risk. Drospirenone-containing pills may have a higher clot risk than pills with some other progestins. Risk is greatest in the first 6 months, and in women who smoke, are obese, or have other risk factors. Stop immediately and get help for chest pain, leg swelling, or sudden vision or speech changes.
- Smoking over age 35: Do not use this medication if you are over 35 and smoke — the risk of heart attack, stroke, and death from blood clots is significantly increased.
- High potassium (hyperkalemia): Drospirenone can raise potassium levels, especially in women taking certain blood pressure or kidney medications. This can be dangerous. Your potassium should be checked during the first treatment cycle if you take such medications.
- High blood pressure: Monitor blood pressure regularly. Stop the pill if blood pressure rises significantly. Do not use if you have uncontrolled high blood pressure.
- Liver problems: Stop the pill if you develop jaundice (yellowing of skin or eyes). Do not use if you have liver disease or liver tumors.
- Depression: Women with a history of depression should be monitored closely; stop the pill if serious depression returns.
- Migraine: New, worsening, or frequent migraines — especially with neurological symptoms — may require stopping the medication.
🔀What it interacts with▾
This medication can interact with several drugs and supplements — always tell your doctor and pharmacist everything you take:
- Seizure medications (phenytoin, carbamazepine, barbiturates, oxcarbazepine, felbamate, topiramate) — can make the pill less effective; use a backup method
- Rifampin (antibiotic) and griseofulvin (antifungal) — reduce pill effectiveness; use a backup method and for 28 days after stopping the enzyme inducer
- St. John's Wort — herbal supplement that can reduce effectiveness and cause breakthrough bleeding
- Ketoconazole, itraconazole, clarithromycin and other strong CYP3A4 inhibitors — can raise drospirenone levels in the blood, increasing high-potassium risk
- ACE inhibitors, potassium-sparing diuretics, NSAIDs, potassium supplements, heparin, aldosterone antagonists — can raise potassium to dangerous levels when combined with drospirenone
- Lamotrigine (seizure medication) — this pill can significantly lower lamotrigine levels, potentially reducing seizure control; dose adjustment may be needed
- Thyroid hormone replacement — this pill raises thyroid-binding proteins; your thyroid hormone dose may need to be increased
- Hepatitis C combination drugs containing ombitasvir/paritaprevir/ritonavir (with or without dasabuvir) — do NOT combine; can cause severe liver enzyme elevations
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you are over 35 and smoke — risk of fatal cardiovascular events is significantly increased
- Do not use if you have kidney impairment or adrenal insufficiency — drospirenone can cause dangerous potassium buildup
- Do not use if you have liver disease or liver tumors (benign or malignant)
- Do not use if you have or have had breast cancer (which may be hormone-sensitive)
- Do not use if you have a history of blood clots, stroke, or heart attack, or conditions that raise clot risk (e.g., certain heart valve disorders, atrial fibrillation, inherited clotting disorders)
- Do not use if you have uncontrolled high blood pressure or diabetes with blood vessel complications
- Do not use if you have migraines with aura and are over 35, or migraines with focal neurological symptoms at any age
- Do not use during pregnancy
- Use with caution if breastfeeding — the pill can reduce milk production; drospirenone passes into breast milk in small amounts
- Safe for postpubertal adolescents at least 14 years old for acne; not for use before the first menstrual period
- Not studied in or intended for postmenopausal women
- Tell your doctor about any history of depression, gallbladder disease, high triglycerides, or hereditary angioedema
🚑If you take too much▾
There are no reports of serious harmful effects from taking too much of this medication, even when children have accidentally ingested it. An overdose may cause nausea and, in females, withdrawal bleeding. Because drospirenone can affect potassium levels, a doctor should check potassium, sodium, and acid-base balance if a significant overdose is suspected.
📡Pharmacodynamics — effects in the body▾
Drospirenone is a progestin with two additional hormone-related properties: it blocks mineralocorticoid receptors (like a mild dose of spironolactone, a water-balancing drug) and has anti-androgenic activity (it counters the effects of testosterone). Ethinyl estradiol, the estrogen component, raises levels of sex hormone-binding globulin (SHBG) and decreases free testosterone circulating in the blood. Together, these effects form the basis of the combination's potential benefit for acne, though the exact relationship between these hormonal changes and acne improvement has not been fully established. More than 90% of study participants showed successful ovulation suppression with this combination.
🔬Pharmacokinetics — how your body processes it▾
Both drospirenone and ethinyl estradiol are absorbed quickly after swallowing a tablet, reaching peak blood levels within about 1 to 2 hours. Drospirenone stays active in the body for roughly 30 hours before it is cleared, and it builds up steadily in the blood over about 8 days of daily use. Ethinyl estradiol has a shorter half-life of about 24 hours. Both hormones are broken down mainly by the liver (using an enzyme called CYP3A4) and are excreted in urine and feces as inactive byproducts. Eating a high-fat meal can slow absorption and modestly reduce the amount of ethinyl estradiol the body takes in, but does not significantly affect drospirenone overall.
📦How to store it▾
Store at 25°C (77°F); excursions permitted to 15-30°C (59 - 86°F) .
📄 Written from Drospirenone / Ethinyl Estradiol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Drospirenone / Ethinyl Estradiol — the kind of thing our pharmacy team would talk through with you at the counter.
What is this pill actually used for — is it just birth control? ▾
How do I take this pill and what happens if I miss one? ▾
What side effects should I expect, and which ones mean I need to call someone? ▾
I smoke — is it safe for me to take this pill? ▾
Will other medications I take interfere with my birth control? ▾
Can I take this pill if I'm breastfeeding or planning to get pregnant? ▾
Is Drospirenone / Ethinyl Estradiol available over the counter? ▾
When was Drospirenone / Ethinyl Estradiol first available? ▾
Who makes Drospirenone / Ethinyl Estradiol? ▾
💬 Answers drafted from Drospirenone / Ethinyl Estradiol’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
📊 Drospirenone / Ethinyl Estradiol across the U.S. market
How Drospirenone / Ethinyl Estradiol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Kit (73) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Drospirenone / Ethinyl Estradiol is used
A general measure of how commonly Drospirenone / Ethinyl Estradiol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Drospirenone / Ethinyl Estradiol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Drospirenone / Ethinyl Estradiol prescribed? Of the 1,596 medications we measure, Drospirenone / Ethinyl Estradiol ranks #240 by Medicaid prescriptions — more than 85% of them.
Utilization by Drospirenone / Ethinyl Estradiol product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
Other Drospirenone / Ethinyl Estradiol products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 17 of 73 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Drospirenone / Ethinyl Estradiol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 17 of 73 listed Drospirenone / Ethinyl Estradiol NDCs with Medicaid activity.
🔍 Compare Drospirenone / Ethinyl Estradiol products
A representative set of FDA-listed product records for Drospirenone / Ethinyl Estradiol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|
| 💊Kits | |||
| — | A-S Medication Solutions × 5 listings | ANDA | View NDC → |
| — | Afaxys Pharma, LLC × 3 listings | ANDA | View NDC → |
| — | Apotex Corp. | ANDA | View NDC → |
| — | Aurobindo Pharma Limited × 4 listings | ANDA | View NDC → |
| — | Bayer HealthCare Pharmaceuticals Inc. × 6 listings | NDA | View NDC → |
| — | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| — | Camber Pharmaceuticals, Inc. × 4 listings | ANDA | View NDC → |
| — | Glenmark Pharmaceuticals Inc., USA × 6 listings | ANDA | View NDC → |
| — | Lupin Pharmaceuticals, Inc. × 8 listings | ANDA | View NDC → |
| — | Mylan Pharmaceuticals Inc. × 5 listings | ANDA | View NDC → |
| — | Naari Pte. Limited × 2 listings | ANDA | View NDC → |
| — | Nivagen Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| — | NorthStar Rx LLC | ANDA | View NDC → |
| Oral | Pharmaceutics International, Inc. (Pii) | ANDA | View NDC → |
| — | Proficient Rx LP | ANDA | View NDC → |
| — | Redpharm Drug | ANDA | View NDC → |
| — | RPK Pharmaceuticals, Inc. × 5 listings | ANDA | View NDC → |
| — | RPK Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| — | Teva Pharmaceuticals, Inc. | ANDA | View NDC → |
| — | Teva Pharmaceuticals Usa, Inc. × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| — | Teva Pharmaceuticals USA, Inc. × 2 listings | ANDA | View NDC → |
| — | Teva Pharmaceuticals USA Inc | NDA AUTHORIZED GENERIC | View NDC → |
| — | Xiromed, LLC. × 4 listings | ANDA | View NDC → |
Showing 73 of 73 products — FDA National Drug Code Directory. See every product, package size and price: browse all 73 Drospirenone / Ethinyl Estradiol NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Drospirenone / Ethinyl Estradiol — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Drospirenone / Ethinyl Estradiol in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Drospirenone / Ethinyl Estradiol went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 840781 1 dose form · 3 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 378853No current FDA listingClinical drug / strength (SCD) drospirenone 0.25 MG / ethinyl estradiol 0.5 MGRxCUI 1301016drospirenone 3 MG / ethinyl estradiol 0.02 MGRxCUI 630734drospirenone 3 MG / ethinyl estradiol 0.03 MGRxCUI 284207
Look up RxCUI 840781 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Drospirenone / Ethinyl Estradiol is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Drospirenone / Ethinyl Estradiol belongs to the Progestin class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 31 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Pharmaceutics International, Inc. (Pii) is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.